Medicare Advantage Plans are testing a broad array of complementary health plan innovations stimulated by the Medicare Value-Based Insurance Design (VBID) Model. With an expected enrollment of 27 million beneficiaries by the end of next year, plans are testing more supplemental benefits.

Part of the increase is due to CMS’ announcement of Medicare beneficiaries with End-Stage Renal Disease to now have the option to enroll in an MA plan in 2021.


TO READ THE FULL ARTICLE…

This article is premium content and requires a subscription. If you have a subscription, then please here. If you do not have a subscription, you may purchase one below.

Best Offer: 2-Year Premium

$144.97/Every 2 Years

Get 2-Year Premium
  • 12 bimonthly print issues (accessible in PDF, Nook, Kindle, Apple Library, or digital formats) to The Remington Report
  • Full access to the remingtonreport.com
  • Access to back issues of The Remington Report
  • Download access to the articles archives
  • MarketScan reports
  • Latest news from across the continuum
  • Exclusive premium subscription articles and case studies
  • FutureFocus e-newsletter
  • TrendLens e-newsletter

1-Year Classic

$74.97/Every 1 Year

Get 1-Year Classic
  • 6 bimonthly print issues (accessible in PDF, Nook, Kindle, Apple Library, or digital formats) to The Remington Report
  • Full access to remingtonreport.com.
  • Access to back issues of the Remington Report
  • Download access to the articles archives
  • MarketScan reports
  • Latest news from across the continuum
  • Exclusive premium subscription articles and case studies
  • FutureFocus e-newsletter
  • TrendLens e-newsletter